Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect
Crossref DOI link: https://doi.org/10.1007/s00280-017-3406-6
Published Online: 2017-08-03
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Solymosi, Tamás
Ötvös, Zsolt
Angi, Réka
Ordasi, Betti
Jordán, Tamás
Molnár, László
McDermott, John
Zann, Vanessa
Church, Ann
Mair, Stuart
Filipcsei, Genovéva
Heltovics, Gábor
Glavinas, Hristos http://orcid.org/0000-0003-4785-2713
License valid from 2017-08-03